Concurrently, Fitch assigned its “AA-” issuer default rating to MNMC. Additionally, Fitch assigned its “AA-” rating to MNMC’s proposed $65.9 million series 2018A and $18.5 million series 2018B revenue bonds.
The upgrade and assignment are a result of several factors, including the medical center’s dominant market position, expanding service area, strong operating performance and favorable leverage metrics.
The outlook is stable.
More articles on healthcare finance:
Donations to USC medical school fall 55% after dean, faculty scandals
U of Texas Health renames cancer center after donors of $25M gift
6 latest hospital credit downgrades
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
